🟢 Decoy Therapeutics is trading 6.8% up today after preclinical data indicated once-weekly dosing potential

Decoy Therapeutics is trading at $1.10, up 6.80%, after reporting third-quarter progress that included preclinical data indicating its lead pan-coronavirus candidate may support once-weekly dosing.

• The company expects to file a CTA or IND in the second half of 2027.
• Cash totaled $8.1 million at September 30, 2026.
• The stock closed at $1.03 on November 2.